Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Videos Gallery
  • Cell lines for optimizing biotherapeutic production workflows
cell-line-optimization-hero
Webinar

Cell lines for optimizing biotherapeutic production workflows

Dr Allyn Spear discusses Elanco animal health’s experience implementing Revvity’s CHOSOURCE GS knockout cell line for building a biotherapeutics research program in animal health.

Hear about:

  • The various animal health biopharma applications
  • Culture and media used with the CHOSOURCE cell line
  • Testing and optimizing transfection, selection, and integration processes
  • Platform for single-cell cloning for cell line development workflows
  • Titer testing and scale-up of therapeutic expressing clones

The CHOSURCE Platform is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.

bioproduction-video-thumbnail
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.